AI-powered Smart Bionic Eye to Restore Useful Vision
Towards a Smart Bionic Eye: AI-Powered Artificial Vision for the Treatment of Incurable Blindness
This project will create an AI-driven bionic eye to provide practical artificial vision for people with incurable blindness.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Santa Barbara NIH-funded |
| Lab location | 1 site (Santa Barbara, United States) |
| Project ID | NIH-11012426 on NIH RePORTER |
What this research studies
If you have severe vision loss that cannot be fixed with gene or stem cell therapies, this work is trying to build a new kind of bionic eye that uses artificial intelligence to make sense of the world for you. The team combines neuroscience, computer vision, and human-computer interaction to turn electrode stimulation into signals your brain can interpret and to highlight important things like faces, obstacles, and objects for daily tasks. Researchers will develop algorithms and device prototypes and test how well AI-based scene understanding improves real-world tasks such as navigation, face recognition, and self-care. The goal is practical, task-focused artificial vision rather than restoring natural sight.
Who could benefit from this research
Good fit: Ideal candidates would be adults with severe, otherwise untreatable blindness from advanced retinal, optic nerve, or cortical damage who cannot benefit from existing gene or cell therapies.
Not a fit: People with mild vision loss, treatable causes of blindness, or intact useful vision are unlikely to benefit from this bionic-eye work.
Why it matters
Potential benefit: If successful, this could give people with incurable blindness a usable form of vision that helps with navigation, recognizing people, and daily self-care.
How similar studies have performed: Earlier visual prostheses have produced only rudimentary light and shape perception, while AI-augmented bionic eyes are a newer and largely unproven approach.
Where this research is happening
Santa Barbara, United States
- University of California Santa Barbara — Santa Barbara, United States (Active)
Researchers
- Principal investigator: Beyeler, Michael — University of California Santa Barbara
- Study coordinator: Beyeler, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.